Colorado's DORA held its Rule 5.4 facilitator continuing education hearing on October 8, 2026, and the Natural Medicine Division lists six 2026 rule items.
Colorado natural medicine rules are being revised on two tracks in 2026, run by two different state agencies. The Colorado Department of Regulatory Agencies (DORA) held a hearing on October 8, 2026, on continuing education for facilitators. The Colorado Department of Revenue (DOR) Natural Medicine Division lists six 2026 rule items on licensing, fees, transfers and healing-center reporting.
We reviewed the DORA hearing bulletin and the Division's 2026 regulatory agenda on October 14, 2026, as a desk review of published notices. Nobody on this site attended the hearing, so this page reports what those notices say and marks what they leave out.
Two sets of changes are moving through Colorado's licensed natural medicine program in 2026: a revision of facilitator continuing education rules at DORA and six rule items at the DOR Natural Medicine Division. DORA's Office of Natural Medicine Licensure held a permanent rulemaking hearing on Rule 5.4, Continuing Education Requirements, on October 8, 2026. As of October 14, 2026, no adoption decision on Rule 5.4 appears in the bulletin or the other pages reviewed.
The Division's 2026 regulatory agenda lists three items scheduled for March with an anticipated hearing in spring 2026. They are licensing updates in the Rule 2000 series, the annual required fee review under Rule 2005, and a new Owner Entity fee under Rule 2005.
Three more items are scheduled for August with an anticipated hearing in fall 2026. They cover transfer-rule clarifications in the Rule 3000 series, healing-center transfers, tracking and reporting in the Rule 8000 series, and an internal reference typo in Rule 9040(G).
The proposed Rule 5.4 text sits in draft rules linked from the DORA bulletin, and this page does not summarize it. The Division's agenda does not report outcomes, final fee amounts or whether the spring items were completed.
Two agencies have published 2026 rulemaking notices, and each covers a different part of the program. DORA's Office of Natural Medicine Licensure handles the rules for Natural Medicine Facilitators and Clinical Facilitators, the two facilitator types named in its hearing bulletin.
For the facilitator continuing education rule, the hearing notice says the decision belongs to the Director of the Division of Professions and Occupations.
The DOR Natural Medicine Division publishes its own 2026 regulatory agenda under rules cited as 1-CCR-213-1. That agenda covers licensing, fees, transfers and reporting for the businesses under those rules, including healing centers.
If your question is about facilitator requirements, follow the DORA hearing bulletin. If your question is about a healing center's license, fees or reports, follow the Division's agenda and the Natural Medicine Division site.
DORA's Office of Natural Medicine Licensure held a permanent rulemaking hearing on Thursday, October 8, 2026, at 9:00 a.m. Mountain time. According to the hearing bulletin sent September 23, 2026, the purpose was to revise the current continuing education rules for Natural Medicine Facilitators and Clinical Facilitators.
The notice calls the hearing a final opportunity for stakeholders before the Director of the Division of Professions and Occupations decides whether to adopt the proposed revisions. Comments and testimony were limited to the topics listed in the notice.
Participation ran through a webinar registration link, and written comments went through an online form. Submitted written comments were viewable in a linked spreadsheet, and the bulletin linked both the hearing notice and the draft rules. The bulletin does not state a deadline for written comments.
We did not summarize the draft text, which sits in the draft rules linked from the bulletin.
If you work as a Colorado facilitator, read the draft rules through the DORA bulletin before you plan continuing education around the proposed revisions. For how another state handles facilitator training, see psilocybin facilitator certification in Oregon.
The DOR Natural Medicine Division's 2026 agenda lists six rule items. Its schedule column gives only a month for each item, and its hearing column gives only a season and year.
Three items concern licensing and fees, all scheduled for March with an anticipated hearing in spring 2026. The Rule 2000 series revision is titled "Licensing updates," and a Rule 2005 revision covers the "Annual required fee review," which the agenda places within the mandatory rule review. A new Rule 2005 item is titled "Creation of Owner Entity fee," and the agenda gives no amount for it.
The Rule 3000 series revision, titled "Clarification of Transfer rules," is scheduled for August with an anticipated hearing in fall 2026.
The Rule 8000 series revision is titled "Clarifying transfers, tracking and reporting requirements for healing centers," also scheduled for August with a fall 2026 hearing. It is the only agenda item whose title names healing centers, so a healing-center operator tracking reporting duties should watch this entry.
Rule 9040(G) carries a revision titled "Internal reference typo," scheduled for August with a fall 2026 hearing.
The agenda does not report outcomes, final fee amounts or whether the spring items were completed. Treat each spring 2026 entry as scheduled and unconfirmed until the Natural Medicine Division site shows a result.
We could not open the Division's fee schedule or the adopted rule text, so we list no fee amounts, reporting frequencies or effective dates. Some 2026 secondary summaries, which we did not verify and do not name, describe a rule update with changes to fees and to how often healing centers report session data.
The Division's 2026 agenda reports no final fee amounts. If you need a current fee or reporting schedule, use the fee schedule and adopted rules on the Colorado Natural Medicine Division site.
The rules under review rest on Proposition 122, the Natural Medicine Health Act, which passed in November 2022 with about 53% of the vote. It decriminalized personal use, possession, growing and gifting of psilocybin, psilocin, DMT, ibogaine and mescaline (excluding peyote) for adults 21 and over. It also created the state-licensed healing-center program that the Division's Rule 8000 series item addresses.
Licensing opened December 31, 2024, and the first healing centers began operating in 2025. The program started with psilocybin, and Colorado has no stores or dispensaries.
Colorado House Bill (HB) 26-1325 was signed by Gov. Jared Polis on June 4, 2026, and took effect August 12, 2026. It creates an Ibogaine Research Pilot Program inside the Behavioral Health Administration with up to five competitively selected pilot sites. The HB 26-1325 entry covers it, and the law does not open ibogaine to the general public.
Both are state laws. For the possession rules in more detail, read is psilocybin legal in Colorado and is DMT legal in Colorado.
No Colorado rule changes federal law. Psilocybin, psilocin, DMT, ibogaine and mescaline remain Schedule I controlled substances under the Controlled Substances Act, according to the U.S. Drug Enforcement Administration (DEA) drug scheduling page.
A Colorado license does not make a substance federally legal or FDA-approved. No psychedelic named on this page is approved by the U.S. Food and Drug Administration (FDA) for any use.
Colorado has no stores or dispensaries, and none of the six agenda item titles mentions retail sales. For how Colorado compares with other states, see the Colorado legal status entry and the full legal status by state tool.
The Rule 5.4 bulletin shows the steps of one Colorado natural medicine rulemaking: a notice with draft rules, a hearing, written comments and a decision by a named official. The DOR agenda adds a schedule for when each item is expected to be heard.
Start with the DORA hearing bulletin, which named the rule, the hearing date and time, and the topics open for comment. Then read the draft rules linked from the bulletin, since comments and testimony at the Rule 5.4 hearing were limited to the listed topics.
To take part in a hearing like this one, register through the webinar link and send written comments through the online form. For Rule 5.4, submitted comments were viewable in a linked spreadsheet.
After the hearing, the next event is the decision. For Rule 5.4, that decision belongs to the Director of the Division of Professions and Occupations, and none is published as of October 14, 2026.
The Division's agenda gives only a month and a season for each item, so watch the Natural Medicine Division 2026 regulatory agenda as each hearing season arrives.
Two agencies have published 2026 rulemaking notices. The Colorado Department of Regulatory Agencies (DORA) Office of Natural Medicine Licensure handles rules for Natural Medicine Facilitators and Clinical Facilitators. The Colorado Department of Revenue Natural Medicine Division publishes rules on licensing, fees, transfers and reporting for businesses, including healing centers.
Rule 5.4 is DORA's rule on Continuing Education Requirements for Natural Medicine Facilitators and Clinical Facilitators. DORA held a permanent rulemaking hearing on October 8, 2026, to revise it. The proposed text is in the draft rules linked from DORA's September 23, 2026 bulletin, and this page does not summarize it.
DORA's hearing on Rule 5.4 was held Thursday, October 8, 2026, at 9:00 a.m. Mountain time, with participation through a webinar registration link. The Natural Medicine Division's 2026 agenda lists separate hearings anticipated in spring 2026 and fall 2026. The agenda gives no exact dates for those hearings.
No adoption decision on Rule 5.4 is published as of October 14, 2026, in the DORA bulletin or the other pages reviewed. The hearing notice says the Director of the Division of Professions and Occupations decides whether to adopt the proposed revisions.
No. Psilocybin, psilocin, DMT, ibogaine and mescaline remain Schedule I controlled substances under the federal Controlled Substances Act. State licensing is not federal approval, and none of these substances is FDA-approved for any use.
The fee schedule belongs to the Colorado Natural Medicine Division, whose official site is dnm.colorado.gov. This page could not open that schedule when it was written, so it states no fee amounts. Secondary summaries describe fee changes, and those changes are unconfirmed on this page.
Proposition 122, passed in November 2022, decriminalized personal use, possession, growing and gifting of psilocybin for adults 21 and over under state law. State-licensed healing centers began operating in 2025, and Colorado has no stores or dispensaries. Psilocybin remains a Schedule I controlled substance under federal law.
Get psilocybin research & policy updates
New trials, FDA decisions, and legal changes for psilocybin — delivered when they happen.
Suggest a tool, topic, or improvement that would make this site more useful.